Evaluation of lipid-lowering therapies at an ethnically diverse clinic [2]

American Journal of Health-System Pharmacy

Volumn 60, Issue 12, 2003, Pages 1282-1283

  Huxtable, Lindsay M ^a   Borowski, Dianna ^b  

^a MIDWESTERN UNIVERSITY   (United States)

^b Maricopa Integrated Health System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DYSLIPIDEMIA; ETHNIC GROUP; FEMALE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LETTER; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT EDUCATION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; BLOOD; CAUCASIAN; CULTURAL ANTHROPOLOGY; DRUG UTILIZATION; ETHNOLOGY; HEALTH CARE DELIVERY; HISPANIC; HYPERLIPIDEMIA; MIDDLE AGED; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; STATISTICS; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE FACILITIES; ANTILIPEMIC AGENTS; ARIZONA; CHOLESTEROL, LDL; CULTURAL DIVERSITY; DRUG UTILIZATION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH SERVICES ACCESSIBILITY; HISPANIC AMERICANS; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE;

EID: 0141609586     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/60.12.1282     Document Type: Letter

References (10)

1. National Heart, Lung, and Blood Institute. National Cholesterol Education Program in Adults. Second report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Bethesda, MD: National Institutes of Health, 1993 Sep; NIH publication no. 93-3095.
2. National Cholesterol Education Program. Third report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). www.nhlbi.nih.gov/guidelines/cholesterol/atp3_rpt.htm (accessed 2002 Jan 15).
3. Brown AS, Cofer LA. Lipid management in a private cardiology practice (the Midwest Heart Experience). Am J Cardiol. 2000; 85: 18A-22A.
4. Harris DE, Record NB, Gipson GW et al. Lipid lowering in a multidisciplinary clinic compared with primary physician management. Am J Cardiol. 1998; 81:929-33.
5. Bogden PE, Koontz LM, Williamson P et al. The physician and pharmacist team; an effective approach to cholesterol reduction. J Gen Intern Med. 1997; 12:158-64.
6. Schectman G, Wolff N, Byrd JC et al. Physician extenders for cost-effective management of hypercholesterolemia. J Gen Intern Med. 1996; 11:277-86.
7. Bozovich M, Rubino CM, Edmunds J. Effect of a clinical pharmacist-managed lipid clinic on achieving National Cholesterol Education Program low-density lipoprotein goals. Pharmacotherapy. 2000; 20:1375-83.
8. DiTusa L, Luzier AB, Brady G et al. A pharmacy-based approach to cholesterol management. Am J Manag Care. 2001; 7:973-9.
9. Shaffer J, Wexler LF. Reducing low-density lipoprotein cholesterol levels in an ambulatory care system. Arch Intern Med. 1995; 155:2330-5.
10. Nelson K, Norris K, Mangione CM. Disparities in the diagnosis and pharmacologic treatment of high serum cholesterol by race and ethnicity. Data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2002; 162:929-35.